Article

Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated…

Bioinorganic Chemistry and Applications · 2022 · Nahed S. Alharthi, author Fahad M. Aldakheel, author Abdulkarim S. Binshaya, author R. Lakshmipathy, Academic Editor

Key facts

Title Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer’s Disease
First author Nahed S. Alharthi, author Fahad M. Aldakheel, author Abdulkarim S. Binshaya, author R. Lakshmipathy, Academic Editor
Journal Bioinorganic Chemistry and Applications
Published Jul 7, 2022
DOI 10.1155/2022/1401995
Devices mentioned K810863, K973350, K990827
Product codes mentioned DBM, JLX, KQP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature